Antiretroviral therapy drug adherence in Rwanda

Rwanda has achieved high enrollment into antiretroviral therapy (ART) programs but data on adherence after enrollment are not routinely collected. We used a mixed-methods approach (standardized questionnaires, pill counts, focus group discussions, and in-depth interviews) to determine levels of and barriers to ART adherence from the perspective of both patients and healthcare workers (HCW). Data were available from 213 patients throughout the first year on ART; 58 of them and 23 HCW participated in a qualitative sub-study. Self-reported adherence was high (96% of patients reporting more than 95% adherence), but adherence by pill count was significantly lower, especially in the first 3 months. In the standardized interviews, patients mostly reported that they "simply forgot" or "were away from home" as reasons for nonadherence. The qualitative research identified three interrelated constructs that appeared to negatively influence adherence: stigma, difficulty coming to terms with illness, and concealment of illness. Both standardized questionnaires and the qualitative research identified poverty, disruption to daily routines, factors related to regimen complexity and side effects, and service-related factors as barriers to adherence. We conclude that regular triangulation of different sources of adherence data is desirable to arrive at more realistic estimates. We propose that program monitoring and evaluation cycles incorporate more in-depth research to better understand concerns underlying reasons for nonadherence reported in routine monitoring

Antiretroviral therapy · Family medicine · Focus group · Health care · Medication adherence · Pill · Psychiatry · Qualitative research · Regimen · Viral load · HIV, Drug Use, Sexual Risk · HIV/AIDS drug development and treatment · HIV/AIDS Research and Interventions · Medicine · Nursing · Internal Medicine · Surgery

• Determinants of adherence to antiretroviral therapy among HIV-positive adults in sub-Saharan Africa

  Open Access•Tessa Heestermans, Joyce L Browne et al.•BMJ Global Health•2016

  Incluir item

• Covid-19-Compliant Strategies for Supporting Treatment Adherence Among People Living with HIV in Sub-Saharan Africa

  Open Access•Thabani Nyoni, Moses Okumu•AIDS and Behavior•2020

  Incluir item

• Antiretroviral therapy adherence measurement in non-clinical settings in South India

  Nora J Kleinman, Lisa E Manhart et al.•AIDS Care•2015

  Incluir item

• The effectiveness of treatment supporter interventions in antiretroviral treatment adherence in sub-Saharan Africa

  Thabani Nyoni, Ya Haddy Sallah et al.•AIDS Care•2020

  Incluir item

• Patient Retention in Antiretroviral Therapy Programs in Sub-Saharan Africa

  Open Access•Sydney Rosen, Matthew P Fox et al.•PLoS Medicine•2007

  Incluir item

• Adherence to Antiretroviral Therapy in Sub-Saharan Africa and North America

  Edward J Mills, Jean B Nachega et al.•JAMA•2006

  Incluir item

• Correlates and Predictors of Adherence to Highly Active Antiretroviral Therapy

  Adriana Ammassari, Maria Paola Trotta et al.•JAIDS Journal of Acquired Immune…•2002

  Incluir item

• Prevention of HIV-1 Infection with Early Antiretroviral Therapy

  Myron S Cohen, Ying Qing Chen et al.•New England Journal of Medicine•2011

  Incluir item

• Hunger, waiting time and transport costs

  Anita Hardon, A P Hardon et al.•AIDS Care•2007

  Incluir item

• Adherence to Haart

  Sigrid C J M Vervoort, Mieke Grypdonck et al.•AIDS Care•2009

  Incluir item

• “It is not that I forget, it's just that I don't want other people to know”

  Vu Van Tam, Anastasia Pharris et al.•AIDS Care•2011

  Incluir item

• Stigma rises despite antiretroviral roll-out

  Open Access•Brendan Maughan-Brown•Social Science & Medicine•2010

  Incluir item